PVR Inox
Exhibition duopoly-of-one at book
- Last close
- ₹1,190.10
- 29 Sept 2026 · reference
- 1D · 1M
- −2.8% · −2.5%
- price-only
- Weight
- 1.5%
- 31 Jul 2026 · Aug rank 24
- Thesis review
- 8 Sep 2026
- Why We Own, p64
Exhibition duopoly-of-one at book — what has to happen, what we believe, what breaks it
- H2 FY27 (Oct-Dec 2026) festive slate plus bunched Q2/Q3 screen openings (~100 for FY27) - Q3FY27 results in Jan-2027 are the key print.
- Zero net debt milestone targeted by end-FY27 (Mar-2027) enabling a return to dividends/higher ROCE toward pre-COVID levels.
- Ormax/FICCI CY2026 box office: trend implies >Rs 15,000 cr full-year (record) if H2 holds.
- Volume + price + spend all growing: Q1FY27 admissions +8% (36.6 mn), ATP +8% (Rs 273), F&B SPH +9% (Rs 161) with no Rs 500 cr+ blockbuster in H1 CY26 - a weak-content quarter still doubled pre-Ind AS 116 EBITDA to Rs 230 cr.
- Balance-sheet repair nearly done: net debt ~Rs 1,100 cr (Jun-2026 est.) targeted at zero by end-FY27 via Rs 600-800 cr annual operating cash flow, ~Rs 100 cr non-core asset sales and 100% internally funded capex (FY26 capex Rs 254 cr, -24% YoY); interest savings ~Rs 150 cr/yr.
- Capital-light growth: signed pipeline of 138 screens (52 FOCO, 86 asset-light) and ~100 screen openings guided for FY27 (150-160 longer-run) on top of 1,798 screens; 55% of FY26 additions were capital-light and 44% were in South India.
- Structural under-screening: India has 6.8 screens per million vs China 64 / USA 109 and only 3,150 of 19,500 pin codes have a cinema (FICCI-EY 2026), while box office hit a record Rs 13,395 cr in CY25 and Rs 6,398 cr in H1 CY26 (+10%).
- Earnings inflection at a modest multiple: FY26 was the first profitable year post-merger (PAT Rs 333 cr vs -Rs 281 cr) and Buoyant's FY28e P/E of 21.5x is roughly half the trailing multiple.
- Core · Small cap1.5% of PMS · rank 24
- Content dependence: no Rs 500 cr+ film in H1 CY26; a weak Diwali/H2 slate would stall admissions (FY26 Q4 admissions grew only 1.5% - growth was mostly pricing).
- Advertising recovery lagging: FY26 ad revenue Rs 464 cr (+3.6%) is still below pre-COVID and management said brands need 'more proof of concept'; ad is the highest-margin line.
- Regulatory/licensing delays bunch screen openings, and state-level ticket-price caps (Karnataka/Tamil Nadu precedents) or OTT window compression could hit ATP; interest coverage is still flagged 'low' by screener and ROE is only ~5%.
Thesis and position rationale
- Investment case
- Exhibition duopoly-of-one at book
- Why this business
India's largest multiplex chain (merger of PVR and INOX in 2023) with 1,798 screens across 359 cinemas in 113 cities at Mar-26 - roughly 40% of India's multiplex screens and ~18% of the country's 10,033 total screens. Revenue comes from box office (~52%), F&B (~30%), advertising and convenience fees; FY26 admissions were 150 mn at an ATP of Rs 280 and F&B spend per head Rs 147. Expansion has shifted to capital-light FOCO/asset-light formats (55% of FY26 additions) to reach zero net debt.
- What we believe
- 01Volume + price + spend all growing: Q1FY27 admissions +8% (36.6 mn), ATP +8% (Rs 273), F&B SPH +9% (Rs 161) with no Rs 500 cr+ blockbuster in H1 CY26 - a weak-content quarter still doubled pre-Ind AS 116 EBITDA to Rs 230 cr.
- 02Balance-sheet repair nearly done: net debt ~Rs 1,100 cr (Jun-2026 est.) targeted at zero by end-FY27 via Rs 600-800 cr annual operating cash flow, ~Rs 100 cr non-core asset sales and 100% internally funded capex (FY26 capex Rs 254 cr, -24% YoY); interest savings ~Rs 150 cr/yr.
- 03Capital-light growth: signed pipeline of 138 screens (52 FOCO, 86 asset-light) and ~100 screen openings guided for FY27 (150-160 longer-run) on top of 1,798 screens; 55% of FY26 additions were capital-light and 44% were in South India.
- 04Structural under-screening: India has 6.8 screens per million vs China 64 / USA 109 and only 3,150 of 19,500 pin codes have a cinema (FICCI-EY 2026), while box office hit a record Rs 13,395 cr in CY25 and Rs 6,398 cr in H1 CY26 (+10%).
- 05Earnings inflection at a modest multiple: FY26 was the first profitable year post-merger (PAT Rs 333 cr vs -Rs 281 cr) and Buoyant's FY28e P/E of 21.5x is roughly half the trailing multiple.
- Why now
TTM P/E 35.8x on TTM EPS Rs 45.3 (flattered by FY26 divestment gain); P/B 1.54x (1157/751) is near the low end of its post-merger range with the stock -10% from the 52-wk high of Rs 1,284. EV/EBITDA left null: screener borrowings Rs 6,779 cr include lease liabilities… EV/EBITDA n.m.; dividend yield 0.0%.
- Market disagreement
- No listed multiplex peer of scale: PVR INOX has 1,798 screens vs the next chains (Cinepolis India ~400+, Miraj ~200, unlisted/private) - it owns ~40% of multiplex screens and a larger share of premium formats (286 premium screens across 10 formats), giving it the best terms with studios, advertisers and mall developers; scale is the moat.
- Studio/content stocks (e.g. Saregama, Tips, Zee): Exhibitors are content-agnostic - PVR INOX benefits whichever film works (Hindi share rose to 44% of H1-26 box office) whereas producers carry hit-or-miss risk on each slate.
- OTT platforms (Netflix, JioStar - unlisted): Not investable domestically; direct-to-OTT film releases halved from 60 (2024) to 30 (2025) as theatrical windows re-established, and theatrical was 63% of filmed-entertainment revenue in 2025 (FICCI-EY).
- Position sizing
Core Small cap 1.5% of the PMS on $31 Jul 2026 (August rank 24). Core positions are owned through the cycle for leadership and cash-flow quality.
- Catalysts
- H2 FY27 (Oct-Dec 2026) festive slate plus bunched Q2/Q3 screen openings (~100 for FY27) - Q3FY27 results in Jan-2027 are the key print.
- Zero net debt milestone targeted by end-FY27 (Mar-2027) enabling a return to dividends/higher ROCE toward pre-COVID levels.
- Ormax/FICCI CY2026 box office: trend implies >Rs 15,000 cr full-year (record) if H2 holds.
- Risks and response
- Content dependence: no Rs 500 cr+ film in H1 CY26; a weak Diwali/H2 slate would stall admissions (FY26 Q4 admissions grew only 1.5% - growth was mostly pricing).
- Advertising recovery lagging: FY26 ad revenue Rs 464 cr (+3.6%) is still below pre-COVID and management said brands need 'more proof of concept'; ad is the highest-margin line.
- Regulatory/licensing delays bunch screen openings, and state-level ticket-price caps (Karnataka/Tamil Nadu precedents) or OTT window compression could hit ATP; interest coverage is still flagged 'low' by screener and ROE is only ~5%.
- Thesis-break conditions
- Not stated separately on this page; the risk list carries the monitoring triggers.
- Review history
- 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p64) · portfolio as of $31 Jul 2026
- 31 Aug 2026 · Classification in the August top-30: Turnaround (July book: Core)
Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p64. Internal; external publication of these fields is controlled by audience policy.
Internal actions
- HoldPosition carried into August at rank 24.
- ReviewNext scheduled: post 2QFY27 results (Oct–Nov 2026).
Add/trim/exit decisions require transactions data; none supplied. Recording a decision needs a persistence adapter (not configured).
Sector datapoints
- India gross box office was a record Rs 13,395 cr in CY2025; H1 CY2026 was Rs 6,398 cr, +10% YoY, with footfalls 37.8 cr (+5%) and 'Dhurandhar: The Revenge' ~20% of the total (Ormax, Jul-2026); PVR INOX says total box office grew 20% YoY in Apr-Jun 2026.
- Screen count: 10,033 screens in India in 2025 (+1%); 240 added, 124 (mostly single screens) closed; screen density 6.8 per million vs USA 109, France 95, UK 66, China 64 (FICCI-EY 2026).
- Multiplex share: PVR INOX 1,798 screens/359 cinemas at Mar-26 (~40% of multiplex screens); it added 93 and closed 18 screens in FY26.
- Content mix: Hindi rose to 44% of H1-26 box office (from 39%), Tamil fell to 12% (from 17%); six films crossed Rs 200 cr vs four in H1-25 (Ormax).